REFERENCES

1. Scimago Journal & Country Rank. 2023. Available from: https://www.scimagojr.com/countryrank.php. [Last accessed on 26 June 2023].

2. Paim J, Travassos C, Almeida C, Bahia L, Macinko J. The Brazilian health system: history, advances, and challenges. Lancet 2011;377:1778-97.

3. Homma A, Tanuri A, Duarte AJ, et al. Vaccine research, development, and innovation in Brazil: a translational science perspective. Vaccine 2013;31 Suppl 2:B54-60.

4. Peres KC, Buendgens FB, Prates EA, et al. Vaccines in Brazil: historical analysis of the Sanitary registration and vaccine availability in the Brazilian Unified Health System. Cien Saude Colet 2021;26:5509-22.

5. Benchimol J. How Brazil joined the quest for a yellow fever vaccine. Interview by Claudia Jurberg and Julia D'Aloisio. Bull World Health Organ 2013;91:165-6.

6. Xeyla R. Brasil retoma exportação de vacina contra febre amarela. 2019. Available from: https://portal.fiocruz.br/noticia/brasil-retoma-exportacao-de-vacina-contra-febre-amarela. [Last accessed on 26 June 2023].

7. Ho PL, Miyaji EN, Oliveira ML, et al. Economical value of vaccines for the developing countries--the case of Instituto Butantan, a public institution in Brazil. PLoS Negl Trop Dis 2011;5:e1300.

8. Raw I, Higashi HG. Auto-suficiência e inovação na produção de vacinas e saúde pública. Estud av 2008;22:155-70.

9. Cohen J. Unfilled vials. Science 2016;351:16-9.

10. Koff WC, Berkley SF. A universal coronavirus vaccine. Science 2021;371:759.

11. Murray SM, Ansari AM, Frater J, et al. The impact of pre-existing cross-reactive immunity on SARS-CoV-2 infection and vaccine responses. Nat Rev Immunol 2023;23:304-16.

12. Walker NF, Whitty CJ. Tackling emerging infections: clinical and public health lessons from the West African Ebola virus disease outbreak, 2014-2015. Clin Med 2015;15:457-60.

13. Elston JW, Cartwright C, Ndumbi P, Wright J. The health impact of the 2014-15 Ebola outbreak. Public Health 2017;143:60-70.

14. Morens DM, Fauci AS. Emerging pandemic diseases: how we got to COVID-19. Cell 2020;182:1077-92.

15. Trovato M, Sartorius R, D'Apice L, Manco R, De Berardinis P. Viral emerging diseases: challenges in developing vaccination strategies. Front Immunol 2020;11:2130.

16. Ellwanger JH, Veiga ABG, Kaminski VL, Valverde-Villegas JM, Freitas AWQ, Chies JAB. Control and prevention of infectious diseases from a One Health perspective. Genet Mol Biol 2021;44:e20200256.

17. Ellwanger JH, Kulmann-Leal B, Kaminski VL, et al. Beyond diversity loss and climate change: Impacts of Amazon deforestation on infectious diseases and public health. An Acad Bras Cienc 2020;92:e20191375.

18. Brazil’s brain drain is getting worse. 2021. The Economist. Available from: https://www.economist.com/the-americas/2021/07/24/brazils-brain-drain-is-getting-worse?utm_medium=cpc.adword.pd&utm_source=google&ppccampaignID=19495686130&ppcadID=&utm_campaign=a.22brand_pmax&utm_content=conversion.direct-response.anonymous&gclid=EAIaIQobChMI0vyOuqPg_wIVwWmLCh2tIw4lEAAYASAAEgIn4PD_BwE&gclsrc=aw.ds. [Last accessed on 26 June 2023].

19. Loukas A, Hotez PJ, Diemert D, et al. Hookworm infection. Nat Rev Dis Primers 2016;2:16088.

20. Lancet Infectious Diseases. Monkeypox: a neglected old foe. Lancet Infect Dis 2022;22:913.

21. Instituto Butantan. Vacina contra a dengue desenvolvida pelo Butantan entra na reta final de estudos clínicos. 2021. Available from: https://butantan.gov.br/noticias/vacina-contra-a-dengue-desenvolvida-pelo-butantan-entra-na-reta-final-de-estudos-clinicos. [Last accessed on 26 Jun 2023].

22. Domingues CMAS. Challenges for implementation of the COVID-19 vaccination campaign in Brazil. Cad Saude Publica 2021;37:e00344620.

23. FIOCRUZ - Fundação Oswaldo Cruz. Vacinas contra a Covid-19. 2022. Available from: https://portal.fiocruz.br/vacinascovid19. [Last accessed on 6 Jun 2023].

24. Camargo EP, Gazzinelli RT, Morel CM, Precioso AR. Why do we still have not a vaccine against chagas disease? Mem Inst Oswaldo Cruz 2022;117:e200314.

25. Mapa da vacinação contra Covid-19 no Brasil. 2023. Available from: https://especiais.g1.globo.com/bemestar/vacina/2021/mapa-brasil-vacina-covid/. [Last accessed on 26 June 2023].

26. Ministério da Saúde - Brasil. Vacinômetro COVID-19. 2023. Available from: https://infoms.saude.gov.br/extensions/SEIDIGI_DEMAS_Vacina_C19/SEIDIGI_DEMAS_Vacina_C19.html. [Last accessed on 26 June 2023].

27. Fujita DM, Gomes da Cruz TC, Ferreira EM, Henrique da Silva Nali L. The continuous decrease in Poliomyelitis vaccine coverage in Brazil. Travel Med Infect Dis 2022;48:102352.

28. Nunes L. Cobertura Vacinal do Brasil 2020, Panoramas IEPS, Os relatórios do IEPS. Instituto de Estudos para Políticas de Saúde, 2021. Available from: https://ieps.org.br/wp-content/uploads/2021/05/Panorama_IEPS_01.pdf. [Last accessed on 26 Jun 2023].

29. Silva TMRD, Nogueira de Sá ACMG, Prates EJS, et al. Yellow fever vaccination before and during the covid-19 pandemic in Brazil. Rev Saude Publica 2022;56:45.

30. Silveira MM, Conrad NL, Leivas Leite FP. Effect of COVID-19 on vaccination coverage in Brazil. J Med Microbiol 2021:70.

31. Fernandez M, Matta G, Paiva E. COVID-19, vaccine hesitancy and child vaccination: challenges from Brazil. Lancet Reg Health Am 2022;8:100246.

32. Ilacqua RC, Medeiros-Sousa AR, Ramos DG, et al. Reemergence of yellow fever in brazil: the role of distinct landscape fragmentation thresholds. J Environ Public Health 2021;2021:8230789.

33. Ellwanger JH, Fearnside PM, Ziliotto M, et al. Synthesizing the connections between environmental disturbances and zoonotic spillover. An Acad Bras Cienc 2022;94:e20211530.

34. World Health Organization. Rabies. 2023. Available from: https://www.who.int/health-topics/rabies#tab=tab_1. [Last accessed on 26 June 2023].

35. Ferraz JB, Felício PE. Production systems--an example from Brazil. Meat Sci 2010;84:238-43.

36. Alves AJ, Rocha F, Amaku M, et al. Economic analysis of vaccination to control bovine brucellosis in the States of Sao Paulo and Mato Grosso, Brazil. Prev Vet Med 2015;118:351-8.

37. Morgan E, Lundervold M, Medley G, Shaikenov B, Torgerson P, Milner-gulland E. Assessing risks of disease transmission between wildlife and livestock: the saiga antelope as a case study. Biol Conserv 2006;131:244-54.

38. Randall D, Marino J, Haydon D, et al. An integrated disease management strategy for the control of rabies in Ethiopian wolves. Biol Conserv 2006;131:151-62.

39. Ellwanger JH, Chies JAB. The triad "dogs, conservation and zoonotic diseases" - an old and still neglected problem in Brazil. Perspect Ecol Conserv 2019;17:157-61.

40. Silveira MF, Tonial CT, Goretti K Maranhão A, et al. Missed childhood immunizations during the COVID-19 pandemic in Brazil: analyses of routine statistics and of a national household survey. Vaccine 2021;39:3404-9.

41. Oliveira IS, Cardoso LS, Ferreira IG, et al. Anti-vaccination movements in the world and in Brazil. Rev Soc Bras Med Trop 2022;55:e05922021.

42. Sato APS. What is the importance of vaccine hesitancy in the drop of vaccination coverage in Brazil? Rev Saude Publica 2018;52:96.

43. Moura C, Truche P, Sousa Salgado L, et al. The impact of COVID-19 on routine pediatric vaccination delivery in Brazil. Vaccine 2022;40:2292-8.

44. Milani LRN, Busato IMS. Causas e consequências da redução da cobertura vacinal no Brasil. R Saúde Públ Paraná 2021;4:157-71.

45. Goldenberg S, Rodrigues ML, Savino W. Brazilian science: towards extinction? Mem Inst Oswaldo Cruz 2022;116:e210357.

46. Confidence, complacency, convenience model of vaccine hesitancy. 2022. Available from: https://www.local.gov.uk/our-support/coronavirus-information-councils/covid-19-service-information/covid-19-vaccinations/behavioural-insights/resources/3Cmodel-vaccine-hesitancy. [Last accessed on 26 Jun 2023].

47. Report of the SAGE Working Group on vaccine hesitancy. 2014. Available from: https://www.asset-scienceinsociety.eu/sites/default/files/sage_working_group_revised_report_vaccine_hesitancy.pdf. [Last accessed on 26 Jun 2023].